Literature DB >> 6229918

In vitro stimulation of lymphocytes by vascular endothelial cells. A study with canine arterial and venous endothelial cells.

G Groenewegen, W A Buurman, G M Jeunhomme, C J van der Linden, P A Vegt, G Kootstra.   

Abstract

Data are presented on the ability of arterial and venous endothelial cells to stimulate allogeneic leukocytes. Mixed cultures of allogeneic endothelium and lymphocytes result in proliferation of lymphocytes and generation of cell-mediated cytotoxicity, which do not occur in cultures of syngeneic combinations of endothelium and lymphocytes. Studies of kinetics showed a peak in proliferation at days 6-7. The optimal responder-stimulator ratio appeared to be 15:1. Lymphocytes stimulated with venous endothelial cells were cytotoxic both for arterial and for venous endothelial cells and PHA blasts of the stimulator dog, whereas lymphocytes stimulated with arterial endothelial cells lysed only arterial endothelial cells and PHA blasts of the stimulator. Lysis of syngeneic or third-party allogeneic control targets was virtually absent. Optimal conditions for long-term culture of effector cells from mixed leukocyte endothelial cell cultures were analyzed. Addition of Il 2 every 3 days and the original stimulating antigen every 6 days permitted continuous proliferation of these cytotoxic lymphocytes with preservation of the cytotoxicity pattern.

Entities:  

Mesh:

Year:  1984        PMID: 6229918     DOI: 10.1097/00007890-198402000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Microvascular phenomena during pancreatic islet graft rejection.

Authors:  M D Menger; B Wolf; R Höbel; H U Schorlemmer; K Messmer
Journal:  Langenbecks Arch Chir       Date:  1991

2.  Different microvascular endothelial cell phenotypes exhibit different class I and II antigens under interferon-gamma.

Authors:  K Spanel-Borowski; G Bein
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-08       Impact factor: 2.416

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.